MAP9/ERCC3 signaling cascade: A new insight on understanding the chromosomal instability in hepatocellular carcinoma

[1]  Jun Yu,et al.  Microtubule associated protein 9 inhibits liver tumorigenesis by suppressing ERCC3 , 2020, EBioMedicine.

[2]  Jun Yu,et al.  MAP9 Loss Triggers Chromosomal Instability, Initiates Colorectal Tumorigenesis, and Is Associated with Poor Survival of Patients with Colorectal Cancer , 2019, Clinical Cancer Research.

[3]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[4]  N. McGranahan,et al.  The causes and consequences of genetic heterogeneity in cancer evolution , 2013, Nature.

[5]  J. Brondello,et al.  Induction of ASAP (MAP9) contributes to p53 stabilization in response to DNA damage , 2012, Cell cycle.

[6]  Ronald A. DePinho,et al.  Hepatocellular carcinoma pathogenesis: from genes to environment , 2006, Nature Reviews Cancer.

[7]  C. Prigent,et al.  ASAP, a human microtubule-associated protein required for bipolar spindle assembly and cytokinesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Rui Li,et al.  An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma , 2005, Oncogene.

[9]  Francis Simon,et al.  Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3. , 2002, Biochimica et biophysica acta.

[10]  C. Rao,et al.  Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer. , 2017, Carcinogenesis.